AU2001288972A1 - Antipsychotic sulfonamide-heterocycles, and methods of use thereof - Google Patents
Antipsychotic sulfonamide-heterocycles, and methods of use thereofInfo
- Publication number
- AU2001288972A1 AU2001288972A1 AU2001288972A AU8897201A AU2001288972A1 AU 2001288972 A1 AU2001288972 A1 AU 2001288972A1 AU 2001288972 A AU2001288972 A AU 2001288972A AU 8897201 A AU8897201 A AU 8897201A AU 2001288972 A1 AU2001288972 A1 AU 2001288972A1
- Authority
- AU
- Australia
- Prior art keywords
- antipsychotic
- heterocycles
- sulfonamide
- methods
- antipsychotic sulfonamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23160700P | 2000-09-11 | 2000-09-11 | |
| US60/231,607 | 2000-09-11 | ||
| PCT/US2001/028267 WO2002022579A2 (en) | 2000-09-11 | 2001-09-10 | Antipsychotic sulfonamide-heterocycles, and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001288972A1 true AU2001288972A1 (en) | 2002-03-26 |
Family
ID=22869943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001288972A Abandoned AU2001288972A1 (en) | 2000-09-11 | 2001-09-10 | Antipsychotic sulfonamide-heterocycles, and methods of use thereof |
Country Status (3)
| Country | Link |
|---|---|
| US (2) | US6703383B2 (en) |
| AU (1) | AU2001288972A1 (en) |
| WO (1) | WO2002022579A2 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002022572A2 (en) * | 2000-09-11 | 2002-03-21 | Sepracor, Inc. | Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| US7294637B2 (en) * | 2000-09-11 | 2007-11-13 | Sepracor, Inc. | Method of treating addiction or dependence using a ligand for a monamine receptor or transporter |
| US7153858B2 (en) | 2003-01-31 | 2006-12-26 | Epix Delaware, Inc. | Arylpiperazinyl compounds |
| JP2009512711A (en) | 2005-10-21 | 2009-03-26 | ブレインセルス，インコーポレイティド | Regulation of neurogenesis by PDE inhibition |
| JP2009513672A (en) | 2005-10-31 | 2009-04-02 | ブレインセルス，インコーポレイティド | GABA receptor-mediated regulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| WO2007134077A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| UA99259C2 (en) * | 2006-06-16 | 2012-08-10 | Теракос, Инк. | Treating obesity with muscarinic receptor m1 antagonists |
| US8748419B2 (en) * | 2006-06-16 | 2014-06-10 | Theracos, Inc. | Treating obesity with muscarinic receptor M1 antagonists |
| MX2009002496A (en) | 2006-09-08 | 2009-07-10 | Braincells Inc | Combinations containing a 4-acylaminopyridine derivative. |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| SG175925A1 (en) | 2009-05-15 | 2011-12-29 | Novartis Ag | Aryl pyridine as aldosterone synthase inhibitors |
| AU2010275477A1 (en) * | 2009-07-23 | 2012-02-23 | Vanderbilt University | Substituted benzoimidazolesulfonamides and substituted indolesulfonamides as mGluR4 potentiators |
| PL395470A1 (en) | 2011-06-29 | 2013-01-07 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Alicyclic amines sulfonamide derivatives for the treatment of diseases of the central nervous system |
| WO2020087031A1 (en) | 2018-10-26 | 2020-04-30 | The Research Foundation For The State University Of New York | Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3534049A (en) * | 1968-04-12 | 1970-10-13 | American Home Prod | 1 - substituted - 3 - (1 - hydroxy - n - (arylsulfonyl)formimidoyl)pyridines and derivatives |
| DE2347390A1 (en) * | 1973-09-17 | 1975-04-03 | Schering Ag | Pyrido-/1,4/-oxazepines and -diazepines - prepd. by reacting 2-(amino- or hydroxy-methyl)-piperidines with carbonyl cpds. |
| US3933829A (en) * | 1974-08-22 | 1976-01-20 | John Wyeth & Brother Limited | 4-Aminoquinoline derivatives |
| DE2718405A1 (en) | 1977-04-26 | 1978-11-02 | Boehringer Sohn Ingelheim | NEW N-NECK CLAMP ON 1- (3-BENZOYLPROPYL) -4-PIPERIDYL NECK CLAMP ON -SULPHONIC ACID AMIDES AND METHOD FOR THE PRODUCTION THEREOF |
| US5994392A (en) | 1988-02-26 | 1999-11-30 | Neuromedica, Inc. | Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid |
| DE4032766A1 (en) | 1990-10-16 | 1992-04-30 | Basf Ag | PHENYLPIPERIDINOYLAMINE AND MEDICINAL PRODUCTS CONTAINING THEM |
| GB9202238D0 (en) | 1992-02-03 | 1992-03-18 | Wellcome Found | Compounds |
| DK0655996T3 (en) | 1992-08-19 | 2001-12-27 | Pfizer | Substituted benzylamino nitrogen-containing, non-aromatic heterocyclic compounds |
| EP1209157A1 (en) | 1993-09-17 | 2002-05-29 | Pfizer Inc. | Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds |
| HU217837B (en) | 1994-05-18 | 2000-04-28 | EGIS Gyógyszergyár Rt. | Acid-amide derivatives, pharmaceutical compositions containing them and process for producing them |
| IL117798A (en) * | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases and pharmaceutical compositions comprising them |
| US6194581B1 (en) | 1995-04-07 | 2001-02-27 | Merck & Co., Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
| US5794887A (en) | 1995-11-17 | 1998-08-18 | Komerath; Narayanan M. | Stagnation point vortex controller |
| AU2680797A (en) | 1996-04-24 | 1997-11-12 | Emory University | Halogenated naphthyl methoxy piperidines for mapping serotonin transporter sites |
| GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| ATE276242T1 (en) * | 1997-05-30 | 2004-10-15 | Banyu Pharma Co Ltd | 2-OXOIMIDAZOLE DERIVATIVES |
| US6004982A (en) * | 1997-09-15 | 1999-12-21 | Hoechst Marion Roussel, Inc. | 4-piperidinyl) H-2-benzopyran derivatives useful as antipsychotic agents |
| KR20010042001A (en) | 1998-03-19 | 2001-05-25 | 무라타 도시카즈 | Arylpiperidine derivatives and use thereof |
| US6407103B2 (en) * | 1998-04-21 | 2002-06-18 | Bristol-Myers Squibb Pharma Company | Indeno [1,2-c] pyrazol-4-ones and their uses |
| FR2805817B1 (en) | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | PHARMACEUTICAL COMPOSITIONS CONTAINING AZETIDINE DERIVATIVES, NOVEL AZETIDINE DERIVATIVES AND THEIR PREPARATION |
| FR2805810B1 (en) | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | PHARMACEUTICAL COMPOSITIONS CONTAINING 3- AMINO-AZETIDINE DERIVATIVES, THE NEW DERIVATIVES AND THEIR PREPARATION |
| WO2009090653A2 (en) | 2008-01-16 | 2009-07-23 | Technion Research & Development Foundation Ltd | Spectrum manipulation device and method |
-
2001
- 2001-09-10 AU AU2001288972A patent/AU2001288972A1/en not_active Abandoned
- 2001-09-10 WO PCT/US2001/028267 patent/WO2002022579A2/en not_active Ceased
- 2001-09-12 US US09/951,137 patent/US6703383B2/en not_active Expired - Lifetime
-
2004
- 2004-01-28 US US10/766,300 patent/US6872716B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6872716B2 (en) | 2005-03-29 |
| WO2002022579A3 (en) | 2003-01-09 |
| US6703383B2 (en) | 2004-03-09 |
| US20020065265A1 (en) | 2002-05-30 |
| WO2002022579A2 (en) | 2002-03-21 |
| US20040235832A1 (en) | 2004-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
| AU2002226486A1 (en) | Novel c-glycoside derivatives and use thereof | |
| AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
| AU2002226487A1 (en) | Novel c-glycoside derivatives and use thereof | |
| AU2002314466A1 (en) | Withasol and methods of use | |
| AU2001280599A1 (en) | Compounds and methods | |
| AU2001253418A1 (en) | Compounds and methods | |
| AU2001294549A1 (en) | Process and intermediates | |
| AU2002224808A1 (en) | Use of thienopyrimidines | |
| AU2001288972A1 (en) | Antipsychotic sulfonamide-heterocycles, and methods of use thereof | |
| AU2002211717A1 (en) | Stresscopins and their uses | |
| AU2002211183A1 (en) | Prosthetic construct and methods for its manufacture and use | |
| AU2002213346A1 (en) | Osteopontin-coated surfaces and methods of use | |
| AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
| AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
| AUPQ872300A0 (en) | Compounds and methods | |
| AU2002363938A1 (en) | Methods and use of motoneuronotropic factors | |
| AU2001278951A1 (en) | Compounds and methods | |
| AU2001290641A1 (en) | Substituted fused pyrroleimines and pyrazoleimines | |
| AU2001269276A1 (en) | Drills and their manufacture | |
| AU2001261496A1 (en) | Luxo-sigma54 interactions and methods of use | |
| AU4432001A (en) | Trityl-type compounds and their use | |
| AU2001252062A1 (en) | Steatosis-modulating factors and uses thereof | |
| AU2001268053A1 (en) | Human sparc-homologous (hsparc-h1) gene and methods and uses thereof | |
| AU2002256556A1 (en) | Sea-trosy and related methods |